Dr. Weishuo Fang is an accomplished researcher specializing in medicinal chemistry, bioactive small-molecule design, and therapeutic target modulation, with particular contributions to FXR modulators, tubulin-binding agents, and BACE1 inhibitors for metabolic, oncological, and neurodegenerative diseases. He has authored over 102 peer-reviewed publications with more than 1,692 citations and maintains a strong h-index of 24, reflecting sustained scientific impact. His work integrates structure-based optimization, pharmacological evaluation, and translational drug discovery approaches. Through extensive interdisciplinary collaborations and high-quality publications in leading journals, his research advances targeted therapeutic strategies and contributes meaningfully to global progress in biomedical and pharmaceutical innovation.